Article

Monoterpene Α-Pinene Alleviates Diabetic Retinopathy in Rodent Model via Attenuating Hyperglycemia Induced VEGF Signaling

Xiao Dong1, Zhanrong Zhang2★★ Corresponding author

  1. 1Department of Ophthalmology, Xidian Group Hospital, Xi'an, Shaanxi Province, CHINA.
  2. 2Department of Fundus Disease, Xi'an Aier Ancient City Eye Hospital, Xi'an, Shaanxi Province, CHINA.

CORRESPONDENCE

Zhanrong Zhang

Department of Fundus Disease, Xi'an Aier Ancient City Eye Hospital, Xi'an, Shaanxi Province, CHINA.

zhanzhan820104@sina.com

Received: 27-05-2025; Revised: 14-07-2025; Accepted: 02-09-2025.

Volume 60, Issue 1 · pp. 312–321 · PUBLISHED 2018 · DOI: 10.5530/ijper.20261413

View on IJPER original site ↗

ABSTRACT

Background: Diabetic Retinopathy (DR) has emerged as a significant global health issue that requires urgent and collaborative action to tackle. As the leading causes of preventable blindness, DR predominantly impacts adults in their working years, posing a significant threat to both individual quality of life and global economic productivity. This research work was aimed at assessing the potency of α-Pinene; a miracle compound on ameliorating hyperglycemia induced diabetic retinopathy in rodent model. Materials and Methods: Male Wistar rats were administered with single shot intraperitoneal 60 mg/kg STZ injection to induce diabetes. The rats exhibited glucose levels 250 mg/dL or higher were classified as diabetic rats and were treated with α-Pinene and a group of diabetic rats were treated with standard anti-hyperglycemic drug metformin. The body weight, feed intake was monitored and the HbA1C, blood glucose levels were quantified to analyse the antihyperglycemic effect of α-Pinene. Results: The lipid profile and atherogenic index were quantified to assess the anti-hypercholesteremic effect of α-Pinene. MDA levels, antioxidants and glutathione levels were measured to examine the antioxidant potency of α-Pinene in hyperglycemic condition. Inflammatory triggering molecules NFκB, TNFα and interleukins 6, 1β were quantified to analyse the inflammatory attenuating effect of α-Pinene. The impact of α-Pinene on VEGF, MMP-9 and MCP-1 were analysed to confirm the attenuating effect of α-Pinene against diabetic retinopathy development and progression. BAX and BCL2 proteins were quantified to examine α-Pinene anti-apoptotic potency in hyperglycemic condition. The retinal thickness and the ganglion cell count were measured to confirm the ameliorating potency of α-Pinene against diabetic retinopathy. Our results demonstrated that α-Pinene is a powerful antioxidant with significant anti-diabetic, anti-hypercholesterolemic, inflammatory modulation, and apoptosis inhibiting effects in a rodent model of diabetic retinopathy. Conclusion: It effectively reduced the initiation and advancement of diabetic induced retinal disorder, as confirmed by histopathological analysis of retinal tissue. In conclusion, α-Pinene is a promising compound with diverse pharmacological properties that can help mitigate diabetic induced retinal disorder.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Dong, X., & Zhang, Z. (2018). Monoterpene Α-Pinene Alleviates Diabetic Retinopathy in Rodent Model via Attenuating Hyperglycemia Induced VEGF Signaling. Indian Journal of Pharmaceutical Education and Research, 60(1), 312–321. https://doi.org/10.5530/ijper.20261413